Summary
Key points about C-reactive protein (CRP)
- What it is: C-reactive protein (CRP) is a protein produced mainly by the liver. Its concentration in the blood increases when there is inflammation in the body.
- What the test is used for: The test helps identify inflammatory and infectious processes and monitor the progression of certain diseases and the response to treatment.
- High CRP: CRP levels may increase due to bacterial or viral infections, autoimmune diseases, injuries, surgery, and other conditions. The test alone cannot identify the cause.
- Normal values: Most healthy people have CRP levels below 3 mg/L (0.3 mg/dL), but reference ranges vary between laboratories.
- Very high CRP: Results above 100 mg/L (10 mg/dL) suggest a significant inflammatory response, often associated with infections, but cannot identify the underlying disease on their own.
- High-sensitivity CRP: This test measures the same protein but can detect much lower concentrations. It is mainly used to provide additional information when assessing cardiovascular risk.
- Normal CRP: A normal result does not rule out an infection or inflammatory disease, especially when the test is performed too early.
What is C-reactive protein?
C-reactive protein, also known as CRP, is a protein produced mainly by the liver. Its concentration in the blood rises rapidly when an inflammatory process is taking place. This inflammation may be caused by infections, cancer, rheumatic diseases, or injuries.
The concentration of C-reactive protein in the blood can be measured with a simple blood test. Nowadays, virtually any laboratory can measure CRP levels.
If CRP is high, it means the body is mounting an inflammatory response, but this does not necessarily indicate an infection. CRP is a nonspecific test. It helps detect and monitor inflammatory processes but cannot determine their cause on its own. In other words, the test may indicate that something is happening in the body, but it cannot tell us which disease is responsible or which organ is affected.
Why do C-reactive protein levels increase?
The liver is responsible for producing many of the proteins that circulate in the bloodstream. When the body is under stress, such as during infections or injuries to organs and tissues, the liver increases its production of several proteins known as acute-phase proteins.
In addition to CRP, this group includes fibrinogen, ferritin, and serum amyloid A. Fibrinogen, for example, contributes to an increase in the ESR (erythrocyte sedimentation rate), another blood test used to assess inflammatory processes. Some proteins behave in the opposite way: albumin, for instance, tends to decrease during inflammation.
These acute-phase proteins participate in the body’s inflammatory response, helping the immune system fight invading organisms, remove damaged cells, and promote tissue repair. Among the many acute-phase proteins, C-reactive protein is one of the most notable.
C-reactive protein was discovered in the 1930s after researchers analyzed blood samples from patients with pneumonia. At the time, they observed that CRP levels were very high during the active phase of pneumonia but decreased once the patient recovered.
It soon became clear that this phenomenon was not limited to pneumonia but also occurred in many other significant infections, particularly those caused by bacteria.
In most cases, very marked increases in CRP are associated with infections, especially bacterial infections, but any inflammatory process can be responsible.
In addition to infections, several other diseases and conditions can cause CRP levels to rise, including:
- Acute appendicitis.
- Acute pancreatitis.
- Inflammatory bowel disease.
- Lymphomas.
- Multiple myeloma.
- Malignant tumors.
- Injuries.
- Burns.
- Myocardial infarction (heart attack).
- Stroke.
- Rheumatoid arthritis.
- Behçet’s disease.
- Scleroderma.
- Granulomatosis with polyangiitis (formerly known as Wegener’s granulomatosis).
- Rheumatic fever.
The diseases listed above are just a few examples. The complete list, including infectious diseases, contains dozens of conditions.
For several decades, we have also known that CRP levels can help identify people at greater risk of developing cardiovascular diseases. Small but persistent increases in CRP are associated with a higher risk of future cardiovascular events, such as heart attacks and strokes (we will explain this in more detail later).
Important: The abbreviation PCR is also used for a technique called polymerase chain reaction, which identifies genetic material, such as DNA or RNA from infectious agents. The RT-PCR test used to diagnose COVID-19 is one example. This article does not discuss that type of PCR because it is a completely different test from measuring C-reactive protein.
What is the C-reactive protein test used for?
C-reactive protein is widely used to help diagnose inflammatory and infectious diseases and to monitor how well their treatment is working.
As mentioned earlier, CRP is a nonspecific test. It tells us that an inflammatory response is taking place, but it provides limited information about the underlying cause.
To identify the source of inflammation or infection, doctors need additional information, including a careful review of the patient’s medical history, signs and symptoms, and other diagnostic tests, such as chest X-rays, urine tests, ultrasound scans, and so on.
CRP is particularly useful when results are compared over time. Knowing that a patient has a CRP level of 80 mg/L may be important, but knowing that it has fallen from 180 to 80 mg/L after starting antibiotics gives us a good indication that treatment is working, especially if the patient’s clinical condition is also improving.
How is the CRP test performed? Is fasting required?
C-reactive protein is measured through a routine blood sample, usually taken from a vein in the arm.
Fasting and other special preparations are not required when CRP is measured on its own. However, if other blood tests are ordered at the same time, specific instructions may apply.
It is also important to tell your doctor which medications you are taking, as some anti-inflammatory treatments, immunosuppressants, and other medications can affect CRP levels.
C-reactive protein in infections
The concentration of C-reactive protein in the blood rises early in many infections.
CRP generally begins to increase about 6 to 8 hours after the inflammatory stimulus starts, reaching higher levels over the following 24 to 48 hours. This timing may vary depending on the disease and the intensity of the inflammatory response.
This means that a normal CRP level during the first few hours of an infection is not enough to rule out an infection.
CRP is useful both for diagnosing and monitoring infections because, as antibiotics begin to work and the infection comes under control, C-reactive protein levels tend to fall.
A patient who continues to have a fever, worsening general condition, and persistently elevated or rising CRP levels after 48 to 72 hours of antibiotic treatment needs to be reassessed. This may indicate that the treatment is not working, that a complication has developed, or that the initial diagnosis needs to be reconsidered.
However, CRP should not be used on its own to determine whether an antibiotic is working. Improvements in symptoms and clinical signs remain essential. In some infections, CRP levels may take a little longer to start falling, even when treatment is appropriate.
Historically, we have relied on the white blood cell count obtained from a complete blood count (CBC) to help diagnose and monitor infections. CRP provides valuable additional information because its levels rise and fall relatively quickly according to the intensity of the inflammatory response.
Nowadays, it is common to use both the CBC and CRP as complementary tests when evaluating infections.
Another important point is that a high CRP level does not necessarily mean that the patient needs antibiotics. Some inflammatory processes are not caused by bacteria.
Bacterial infections generally cause greater increases in CRP than viral infections, but there is considerable overlap between their results. Some viral infections can cause substantial CRP elevations, while certain bacterial infections produce only small increases, particularly in their early stages.
Therefore, there is no CRP value that can reliably distinguish a bacterial infection from a viral infection on its own.
C-reactive protein in rheumatic diseases
Rheumatic and autoimmune diseases can cause chronic inflammation in the body, leading to increased CRP levels.
Unlike many bacterial infections, which can cause very marked increases in CRP, some rheumatic diseases produce smaller but persistent elevations. However, this is not an absolute rule: highly active rheumatic diseases can also cause high CRP levels.
In these cases, CRP can serve as a marker of disease activity.
For example, patients with rheumatoid arthritis who have persistently elevated CRP levels tend to have greater inflammatory activity, which is associated with a higher risk of bone erosions and joint deformities in the medium to long term. A reduction in CRP during treatment may indicate a better response, although the disease can remain active even when CRP levels are normal.
Unlike most rheumatic and autoimmune diseases, systemic lupus erythematosus is somewhat different because disease activity does not always cause a significant increase in CRP.
For this reason, a patient with lupus may experience a disease flare while CRP levels remain normal or only slightly elevated. When CRP rises substantially, an associated infection should be considered, although certain manifestations of lupus itself, such as arthritis and serositis, can also increase CRP levels.
C-reactive protein in cancer
Unlike infections and rheumatic diseases, CRP is not usually used in the diagnostic evaluation of patients with suspected cancer.
This is because not all cancers cause CRP levels to rise, and when they do, the results are difficult to distinguish from those caused by other, more common conditions that also produce inflammation.
There are, however, some exceptions in which CRP may be useful. For example, a persistent, unexplained increase in CRP in a patient previously treated for cancer may prompt the doctor to investigate the possibility of cancer recurrence, although the test is neither specific nor recommended as a standalone test for this purpose.
Another example involves patients with certain types of lymphoma or multiple myeloma. In these cases, elevated CRP levels may be associated with more aggressive disease and a worse prognosis, including shorter survival. However, the usefulness of this marker varies according to the type of cancer, and its results must be interpreted alongside other tests and clinical findings.
CRP may also be part of the follow-up care of some patients with cancer, helping assess infectious and inflammatory complications.
It is important to emphasize that CRP is generally not ordered solely to look for cancer. Likewise, a patient with an unexplained increase in CRP should not conclude that they have a malignant tumor. Infections, inflammatory diseases, and other conditions are much more common causes of elevated CRP.
Normal C-reactive protein levels
CRP results may be reported in either mg/dL or mg/L. Because both units are commonly used by laboratories, I will include both throughout the rest of this article.
Converting between these units is straightforward: 1 mg/dL equals 10 mg/L.
Therefore, a CRP level of 2 mg/dL corresponds to 20 mg/L, while a CRP level of 0.5 mg/dL corresponds to 5 mg/L. Understanding the difference between these units is important to avoid misinterpreting the results.
In healthy people, CRP levels are usually below 0.3 mg/dL (3 mg/L), although levels may be slightly higher in older adults or in certain medical conditions.
Reference ranges also vary from laboratory to laboratory. Some consider CRP levels below 3 mg/L normal, while others use cutoffs of 5 mg/L or even 10 mg/L.
To help interpret the results, we can divide CRP levels into several approximate ranges:
CRP below 0.3 mg/dL (3 mg/L): This is the level found in most healthy people.
CRP between 0.3 and 1.0 mg/dL (3 and 10 mg/L): This may occur with very mild inflammation, such as gingivitis or a common cold, but it can also be found in people with obesity, diabetes, high blood pressure, chronic kidney disease, as well as in smokers and people who are physically inactive.
CRP between 1.0 and 4.0 mg/dL (10 and 40 mg/L): This suggests a more noticeable inflammatory response, which may be caused by infections and various other diseases. Viral infections, such as influenza (flu), mononucleosis, and chickenpox, can cause CRP levels within this range, as can rheumatic diseases and other inflammatory conditions.
CRP between 4.0 and 10 mg/dL (40 and 100 mg/L): This indicates a significant inflammatory response and raises suspicion of a bacterial infection. However, some viral infections can also produce results within this range, as can highly active autoimmune diseases, injuries, and other causes of inflammation.
CRP above 10 mg/dL (100 mg/L): This represents a marked elevation, often associated with significant infections, particularly bacterial infections. However, not all patients with these values have an infection. In a study of 839 adults with CRP levels above 100 mg/L, approximately 55% had an infection as the cause of the elevation. The remaining patients had rheumatic diseases, other inflammatory conditions, cancer, and various other diagnoses.
In cases of sepsis, CRP levels can exceed 20 mg/dL (200 mg/L). However, some patients with serious infections have lower values, particularly during the early stages.
It is important to emphasize that these ranges are only general guidelines, not absolute diagnostic cutoffs. CRP does not directly measure how severe a disease is. A localized infection may produce high values in a clinically stable patient, while another patient with a potentially serious disease may still have only a slightly elevated CRP level.
Is a very low CRP level a problem?
No. Very low CRP levels, including values close to zero or below the detection limit, are not a health problem and do not require treatment. They generally indicate the absence of a significant inflammatory response at that time, although they do not rule out every inflammatory or infectious disease.
What should you do if your C-reactive protein is high?
The first step is to assess the result alongside your symptoms, medical history, and other test results. Elevated CRP does not cause symptoms by itself. Fever, pain, fatigue, and other symptoms, when present, are caused by the underlying disease responsible for the inflammation.
When CRP is only slightly elevated and the patient has no symptoms, a clinical assessment and, depending on the circumstances, repeating the test after a few weeks may be sufficient. However, substantial or persistent elevations may require a more detailed diagnostic evaluation.
There is no CRP value that, on its own, determines whether antibiotics, hospitalization, or emergency care are necessary. The urgency depends primarily on the patient’s clinical condition. Symptoms such as severe shortness of breath, confusion, low blood pressure, or a marked deterioration in general condition require immediate medical attention, regardless of the CRP result.
Can CRP be high without a fever or with a normal blood count?
Yes. The absence of fever does not rule out inflammation or infection, just as a normal complete blood count does not prevent CRP from being elevated.
This is because fever, changes in white blood cell counts, and the production of C-reactive protein are different responses of the body. They do not necessarily occur at the same time or with the same intensity.
In addition, CRP may be elevated for reasons that do not cause fever, such as chronic inflammatory diseases, injuries, obesity, and certain metabolic conditions.
Therefore, it would be incorrect to consider a CRP level of 40 mg/L normal simply because the patient has no fever or their blood count shows no abnormalities.
What do positive CRP, reactive CRP, and quantitative CRP mean?
In the past, CRP results were often reported simply as positive or negative.
With some methods, if the CRP level exceeded 1.0 mg/dL (10 mg/L), the laboratory would report a positive result, whether the actual concentration was 1.5 mg/dL or 30 mg/dL. As you can imagine, this type of result is of limited use because it cannot distinguish a slight elevation from a very intense inflammatory response.
Some testing methods still report results as “reactive,” “non-reactive,” or similar terms. A reactive result means that C-reactive protein was detected above the threshold established by the method used. It does not necessarily mean that a bacterial infection is present.
A quantitative CRP test, on the other hand, reports the actual concentration of the protein in the blood, such as 18 mg/L or 1.8 mg/dL.
Modern quantitative testing methods have made it possible to assess the intensity of the inflammatory response more accurately and monitor changes in CRP levels over time.
Can you have an infection with normal CRP levels?
Yes. Although many infections cause CRP levels to rise, not all produce a detectable increase.
This can happen when the blood sample is collected during the first few hours of the illness, before the liver has produced enough of the protein. It can also occur with certain localized or mild infections.
In addition, patients with advanced liver disease or those taking certain immunosuppressive medications may have a weaker CRP response than expected.
Therefore, a normal result is not enough to rule out an infection when the signs and symptoms suggest one. Many viral infections, even those that cause fever, are associated with normal or only slightly elevated CRP levels.
High CRP in children: What does it mean?
In children, CRP is interpreted according to the same basic principles used in adults: elevated levels may indicate an infectious or inflammatory process, but they do not identify the cause.
The main difference is that the child’s age, symptoms, and general condition are particularly important in the assessment.
For example, a child with fever, difficulty breathing, and elevated CRP needs to be assessed differently from a child whose CRP is only slightly elevated but who is active, feeding normally, and showing no signs of serious illness.
Likewise, a normal CRP level does not rule out a serious bacterial infection, particularly in young infants or during the first few hours of fever.
The need for antibiotics, additional tests, or hospitalization should not be determined by the CRP result alone but by a complete clinical assessment.
High-sensitivity C-reactive protein and cardiovascular disease
Traditional methods of measuring CRP were developed mainly to detect elevations associated with infections and inflammation. Older techniques had difficulty accurately measuring very low concentrations, such as those normally found in healthy people.
For example, when the CRP concentration is below the quantification limit of the method used, the laboratory may simply report “CRP < 0.3 mg/dL” or “CRP < 3 mg/L.” This does not mean that the protein is absent from the blood, but rather that its concentration is below the level that the method can measure accurately.
More sensitive methods have made it possible to assess these low concentrations in greater detail.
A test called high-sensitivity C-reactive protein (hs-CRP) can accurately measure very low CRP levels, including concentrations below 0.03 mg/dL (0.3 mg/L).
It is important to understand that high-sensitivity CRP is not a different protein. The test measures exactly the same substance but uses a laboratory method capable of detecting lower concentrations.
This capability has made it possible to use hs-CRP as an additional marker of cardiovascular risk. Let us briefly explain why this matters.
Evidence accumulated since the 1990s has increasingly pointed to inflammation playing a central role in the development of atherosclerosis and, consequently, cardiovascular diseases such as heart attacks.
Several studies have shown that small, persistent increases in C-reactive protein are associated with a higher risk of cardiovascular events, even in people who have no symptoms of infection or inflammation.
This does not mean that CRP itself is responsible for the development of atherosclerotic plaques. It acts primarily as a marker of the inflammatory activity associated with this process.
In healthy people, high-sensitivity CRP levels are usually low, often below 0.1 mg/dL (1 mg/L).
Traditionally, hs-CRP results have been classified as follows:
- Below 0.1 mg/dL (1 mg/L): An inflammatory marker level associated with lower cardiovascular risk.
- Between 0.1 and 0.3 mg/dL (1 and 3 mg/L): Intermediate range.
- Above 0.3 mg/dL (3 mg/L): An inflammatory marker level associated with higher cardiovascular risk.
However, these ranges do not represent a person’s overall cardiovascular risk. A patient with an hs-CRP level below 1 mg/L may still have a high risk of heart attack because of other factors, such as very high cholesterol, diabetes, or smoking.
Similarly, an hs-CRP level above 3 mg/L does not mean that the patient has blocked coronary arteries or will necessarily suffer a heart attack.
The test provides additional information that must be interpreted alongside age, blood pressure, cholesterol levels, diabetes, smoking status, family history, and other risk factors.
When is high-sensitivity CRP important?
One application of high-sensitivity CRP is to help assess patients whose cardiovascular risk is not clearly established by traditional risk factors.
The most recent recommendations from the American College of Cardiology (ACC) and the American Heart Association (AHA), published in 2026, recognize that high-sensitivity CRP levels of 2 mg/L (0.2 mg/dL) or higher, confirmed on two separate occasions and without another identifiable cause of inflammation, may help guide the decision to start statin treatment in certain patients with borderline cardiovascular risk.
The 2025 Brazilian Guideline on Dyslipidemia and Atherosclerosis Prevention also considers an hs-CRP level of 2 mg/L or higher to be a cardiovascular risk-enhancing factor.
This does not mean that everyone with an hs-CRP level above 2 mg/L needs to take cholesterol-lowering medication. The decision depends on an assessment of their overall cardiovascular risk.
The test may also provide information about what is known as residual inflammatory risk in patients who already have cardiovascular disease, even when they are receiving appropriate treatment to control their cholesterol levels.
On the other hand, high-sensitivity CRP testing is not essential for everyone and does not replace the assessment of traditional cardiovascular risk factors.
Precautions when interpreting high-sensitivity CRP
High-sensitivity CRP results should not be used to assess cardiovascular risk during an infection, after surgery or an injury, or in other situations that cause acute inflammation.
Under these circumstances, the increase in C-reactive protein probably reflects the inflammatory process occurring at that time, rather than just the chronic inflammation associated with atherosclerosis.
For example, someone with an hs-CRP level of 8 mg/L during an episode of flu should not be classified as having high cardiovascular risk based on that result.
Values above 10 mg/L (1 mg/dL) generally require considering a possible infectious or inflammatory cause first. When the purpose of the test is to assess cardiovascular risk, it may be necessary to repeat the measurement after the acute condition has resolved, often about two weeks later.
Even when the patient feels well, hs-CRP levels can vary somewhat over time. For this reason, persistently elevated values provide more useful information than a single result.
As mentioned earlier, people with diabetes, high blood pressure, those who smoke, and/or those with obesity may have slightly elevated CRP levels. It is therefore not surprising that these conditions have long been recognized as important risk factors for cardiovascular disease.
The main point is that high-sensitivity CRP can help improve cardiovascular risk assessment, but it cannot diagnose cardiovascular disease and does not replace the tests and criteria normally used for that purpose.
- Antonelli M. Acute phase reactants. UpToDate.
- Crea F, Morrow DA. C-reactive protein in cardiovascular disease. UpToDate.
- 2026 ACC/AHA Guideline on the Management of Dyslipidemia. Circulation. 2026.
- Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2025. Arquivos Brasileiros de Cardiologia.
- NICE. Suspected acute respiratory infection in over 16s: assessment at first presentation and initial management. NG237.
- MedlinePlus. C-Reactive Protein (CRP) Test. National Library of Medicine.
- Landry A, et al. Causes and outcomes of markedly elevated C-reactive protein levels. Canadian Family Physician. 2017.
- Pepys MB, Hirschfield GM. C-reactive protein: a critical update. Journal of Clinical Investigation. 2003.
- Kushner I, Antonelli MJ. What should we regard as an “elevated” C-reactive protein level? Annals of Internal Medicine. 2015.
- Woloshin S, Schwartz LM. Distribution of C-reactive protein values in the United States. New England Journal of Medicine. 2005.
Reader questions about this topic
Questions selected by the editor for their relevance to this article.